MedX Health Corp
MDXHF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $1 | $1 |
| % Growth | 7.4% | -10.7% | -9.3% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 39.7% | 40.7% | 47% | 51.4% |
| R&D Expenses | $1 | $1 | $1 | $1 |
| G&A Expenses | $2 | $2 | $2 | $2 |
| SG&A Expenses | $2 | $2 | $3 | $4 |
| Sales & Mktg Exp. | $0 | $1 | $1 | $1 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $2 | $3 | $4 | $5 |
| Operating Income | -$2 | -$3 | -$4 | -$5 |
| % Margin | -470.4% | -663.3% | -757.6% | -810.3% |
| Other Income/Exp. Net | -$1 | -$2 | -$1 | -$1 |
| Pre-Tax Income | -$4 | -$5 | -$5 | -$5 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$4 | -$5 | -$5 | -$5 |
| % Margin | -746% | -1,004.3% | -1,005.4% | -945.4% |
| EPS | -0.014 | -0.023 | -0.028 | -0.03 |
| % Growth | 41.2% | 16.5% | 5.4% | – |
| EPS Diluted | -0.014 | -0.023 | -0.028 | -0.03 |
| Weighted Avg Shares Out | 267 | 197 | 184 | 180 |
| Weighted Avg Shares Out Dil | 267 | 197 | 184 | 180 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $2 | $1 | $1 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$2 | -$2 | -$4 | -$5 |
| % Margin | -460.9% | -521.5% | -747.5% | -806.4% |